Biologic Agents for the Treatment of Rheumatoid Arthritis Maria Victoria Hernandez MD, PhD Medical Director, Rheumatology - Medical Affairs OCTOBER 9, 2018 Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease affecting around 1.5 million people...
Is Marijuana a Replacement for Opioids? Lynn R. Webster, M.D. Vice President, Scientific Affairs Dr. Webster will be presenting a poster at DIA 2018 in Boston on Tuesday, June 26 on A Phase 1 Pilot Trial to Explore Safety, Pharmacokinetics, and Bioavailability of...
Gene Therapy Research and Rare Diseases Amy Raymond, PhD, PMP Clinical Strategy Lead - Center for Rare Diseases Chris Jenkins Principal Partner - Clinical Biosafety Services Join Amy Raymond at World Orphan Drug Congress on Thursday, April 11, 2019, where she'll...
Not Just a Number: Two Sisters' Journey From Both Sides of Clinical Trials Shelby Barry, MBA Clinical Trial Specialist JULY 16, 2019 Shelby Barry, a clinical trial specialist here at PRA, lost her older sister Shannon, 32, on April 11 to Glioblastoma. Shannon...read more
Leading the Way: Veterans Transitioning into Healthcare Careers Ismael Ramirez (USA/USAR) Project Manager Product Registration Andrew Snyder (USMC) Project Manager Product Registration Marilyn Houde (USA/USAR) Project Manager Product Registration JULY 2, 2019...read more
Exploring STEM and Clinical Research Jason Turner Senior Project Manager, Strategic Solutions JUNE 24, 2019 STEM, a concept based on educating children and young adults in four specific academic disciplines: science, technology, engineering, and math, has been...read more
Cancer Research and Clinical Development Since Last ASCO Jim Wise, MS Executive Director, Project Delivery MAY 23, 2019 In the time since we last met for the American Society of Clinical Oncology (ASCO) congress, much has changed in the world of cancer research and...read more
Lupus Awareness Sudipta Chakraborty Senior Medical Writer MAY 22, 2019 Lupus, a chronic autoimmune disease that can damage any part of the body, can take on average nearly six years to diagnose from the time an individual first notices symptoms. What's more, the...read more
Benefits of Diversity in the Workplace Francisca Burtenshaw (Beloso García) Lic. Fil. Clásica, MCIPD, FRSA Director – Human Resources Western Europe and Nordic Region MAY 20, 2019 Living in a globally connected world means we have countless opportunities to connect...read more
Search for a Cure: Type 1 Diabetes Brian J. Frett, MSc Sr. Project Manager On May 4th, with the support of their family, many of their friends, and community, Liam’s family will be walking together in the JDRF One Walk to raise funds for T1D research. If you have the...read more
Why the Measles Virus is Back and What You Can Do About it Darin Seehafer PRA Vaccine Solutions APRIL 26, 2019 More children across the world are being vaccinated against measles than ever before, but progress has been uneven between and within countries, leaving...read more
Gene Therapy Research and Rare Diseases Amy Raymond, PhD, PMP Clinical Strategy Lead - Center for Rare Diseases Chris Jenkins Principal Partner - Clinical Biosafety Services Join Amy Raymond at World Orphan Drug Congress on Thursday, April 11, 2019, where she'll...read more
World Rare Disease Day PRA Event Derek Ansel Clinical Strategy Lead Center for Rare Disease To show support for Global Genes and rare disease awareness, our Blue Bell colleagues contributed donations and wore denim on Rare Disease Day. PRA Cares matched donations...read more
Neurodegenerative Research: A Future Mindset
PRA’s William Holt, DO, discusses the critical need for research into Neurodegenerative disorders, with particular emphasis on the future of clinical development and Alzheimer’s Disease research.